Bayer’s pharma sales will “remain stable” through 2026, division chief Stefan Oelrich, said during the ... toughest year for our turnaround,” CEO Bill Anderson said. The reduction is ...

The outlook raises the stakes for Chief Executive Officer Bill Anderson ... reach between €1 billion to €1.5 billion in 2025, according to pharma head Stefan Oelrich. Bayer also announced efforts to ...

European science is in a strong position, Stefan Oelrich, President of Bayer’s Pharmaceuticals ... Bill Anderson, CEO, at Roche Pharmaceuticals, agreed that Europe had a promising scientific ...

Eli Lilly’s big-selling insulin, Humalog, faces cut-price competition after the US regulator approved a biosimilar from Sanofi. Sanofi’s Admelog (insulin lispro) is approved in type 1 and type ...

At least eight agencies are investigating a recent fire at a Bayer executive’s New Jersey home as a possible arson, authorities said.The fire happened around 7:30 a.m. March 4 “at an occupied ...